Your browser doesn't support javascript.
loading
Tenascin-C Orchestrates an Immune-Suppressive Tumor Microenvironment in Oral Squamous Cell Carcinoma.
Spenlé, Caroline; Loustau, Thomas; Murdamoothoo, Devadarssen; Erne, William; Beghelli-de la Forest Divonne, Stephanie; Veber, Romain; Petti, Luciana; Bourdely, Pierre; Mörgelin, Matthias; Brauchle, Eva-Maria; Cremel, Gérard; Randrianarisoa, Vony; Camara, Abdouramane; Rekima, Samah; Schaub, Sebastian; Nouhen, Kelly; Imhof, Thomas; Hansen, Uwe; Paul, Nicodème; Carapito, Raphael; Pythoud, Nicolas; Hirschler, Aurélie; Carapito, Christine; Dumortier, Hélène; Mueller, Christopher G; Koch, Manuel; Schenke-Layland, Katja; Kon, Shigeyuki; Sudaka, Anne; Anjuère, Fabienne; Van Obberghen-Schilling, Ellen; Orend, Gertraud.
Afiliação
  • Spenlé C; Université Strasbourg, INSERM U1109-MN3T, The Microenvironmental Niche in Tumorigenesis and Targeted Therapy, and The Tumor Microenvironment Laboratory, Hopital Civil, Institut d'Hématologie et d'Immunologie, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Strasbourg, France.
  • Loustau T; Université Strasbourg, INSERM U1109-MN3T, The Microenvironmental Niche in Tumorigenesis and Targeted Therapy, and The Tumor Microenvironment Laboratory, Hopital Civil, Institut d'Hématologie et d'Immunologie, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Strasbourg, France.
  • Murdamoothoo D; Université Strasbourg, INSERM U1109-MN3T, The Microenvironmental Niche in Tumorigenesis and Targeted Therapy, and The Tumor Microenvironment Laboratory, Hopital Civil, Institut d'Hématologie et d'Immunologie, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Strasbourg, France.
  • Erne W; Université Strasbourg, INSERM U1109-MN3T, The Microenvironmental Niche in Tumorigenesis and Targeted Therapy, and The Tumor Microenvironment Laboratory, Hopital Civil, Institut d'Hématologie et d'Immunologie, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Strasbourg, France.
  • Beghelli-de la Forest Divonne S; Université Côte d'Azur, CNRS, INSERM, iBV, Nice, France.
  • Veber R; Centre Antoine Lacassagne, Nice, France.
  • Petti L; Institut de Biologie Moléculaire et Cellulaire, CNRS, UPR3572 Immunologie, Immunopathologie et Chimie Thérapeutique, Institut de Biologie Moléculaire et Cellulaire, Strasbourg, France.
  • Bourdely P; Université Côte d'Azur, CNRS, IPMC, Valbonne-Sophia Antipolis, France.
  • Mörgelin M; Université Côte d'Azur, CNRS, IPMC, Valbonne-Sophia Antipolis, France.
  • Brauchle EM; Colzyx AB, Lund, Sweden.
  • Cremel G; Department of Women's Health, Research Institute of Women's Health, Eberhard Karls University Tübingen, Tübingen, Germany.
  • Randrianarisoa V; The Natural and Medical Sciences Institute (NMI) at the University of Tübingen, Reutlingen, Germany.
  • Camara A; Cluster of Excellence iFIT (EXC 2180) "Image-Guided and Functionally Instructed Tumor Therapies," Eberhard Karls University Tübingen, Tübingen, Germany.
  • Rekima S; Université Strasbourg, INSERM U1109-MN3T, The Microenvironmental Niche in Tumorigenesis and Targeted Therapy, and The Tumor Microenvironment Laboratory, Hopital Civil, Institut d'Hématologie et d'Immunologie, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Strasbourg, France.
  • Schaub S; Université Strasbourg, INSERM U1109-MN3T, The Microenvironmental Niche in Tumorigenesis and Targeted Therapy, and The Tumor Microenvironment Laboratory, Hopital Civil, Institut d'Hématologie et d'Immunologie, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Strasbourg, France.
  • Nouhen K; Institut de Biologie Moléculaire et Cellulaire, CNRS, UPR3572 Immunologie, Immunopathologie et Chimie Thérapeutique, Institut de Biologie Moléculaire et Cellulaire, Strasbourg, France.
  • Imhof T; Université Côte d'Azur, CNRS, INSERM, iBV, Nice, France.
  • Hansen U; Centre Antoine Lacassagne, Nice, France.
  • Paul N; Université Côte d'Azur, CNRS, INSERM, iBV, Nice, France.
  • Carapito R; Centre Antoine Lacassagne, Nice, France.
  • Pythoud N; Université Côte d'Azur, CNRS, IPMC, Valbonne-Sophia Antipolis, France.
  • Hirschler A; Institute for Dental Research and Oral, Musculoskeletal Research, Center for Biochemistry, University of Cologne, Cologne, Germany.
  • Carapito C; Institute for Musculoskeletal Medicine (IMM), University Hospital Muenster, Muenster, Germany.
  • Dumortier H; INSERM U1109, GENOMAX, Strasbourg, France.
  • Mueller CG; INSERM U1109, GENOMAX, Strasbourg, France.
  • Koch M; IPHC, Cronenbourg, France.
  • Schenke-Layland K; IPHC, Cronenbourg, France.
  • Kon S; IPHC, Cronenbourg, France.
  • Sudaka A; Institut de Biologie Moléculaire et Cellulaire, CNRS, UPR3572 Immunologie, Immunopathologie et Chimie Thérapeutique, Institut de Biologie Moléculaire et Cellulaire, Strasbourg, France.
  • Anjuère F; Institut de Biologie Moléculaire et Cellulaire, CNRS, UPR3572 Immunologie, Immunopathologie et Chimie Thérapeutique, Institut de Biologie Moléculaire et Cellulaire, Strasbourg, France.
  • Van Obberghen-Schilling E; Institute for Dental Research and Oral, Musculoskeletal Research, Center for Biochemistry, University of Cologne, Cologne, Germany.
  • Orend G; Department of Women's Health, Research Institute of Women's Health, Eberhard Karls University Tübingen, Tübingen, Germany.
Cancer Immunol Res ; 8(9): 1122-1138, 2020 09.
Article em En | MEDLINE | ID: mdl-32665262

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias Bucais / Tenascina / Carcinoma de Células Escamosas de Cabeça e Pescoço Limite: Animals / Humans Idioma: En Revista: Cancer Immunol Res Ano de publicação: 2020 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias Bucais / Tenascina / Carcinoma de Células Escamosas de Cabeça e Pescoço Limite: Animals / Humans Idioma: En Revista: Cancer Immunol Res Ano de publicação: 2020 Tipo de documento: Article País de afiliação: França